357. Lack of molecular evidence of nosocomial transmission of human rhinovirus in hematopoietic cell transplant recipients
Session: Poster Abstract Session: HAI: Respiratory Infections
Thursday, October 8, 2015
Room: Poster Hall
  • IDweek 2015 FINAL.pdf (537.4 kB)
  • Background: Human rhinoviruses (HRV) are the most common respiratory viruses in hematopoietic cell transplant (HCT) recipients. There is concern for nosocomial transmission of HRVs in HCT patient care settings, but no studies have investigated HRV transmission using molecular techniques.  

    Methods: From 2005-2011, we conducted a surveillance study of allogeneic HCT recipients in which upper respiratory samples and symptom surveys were collected weekly for the first 100 days following HCT, then every 3 months or with new respiratory symptoms for 1 year. Samples were tested by real-time RT-PCR for 15 respiratory viruses, including HRV. Unique HRV episodes were defined when ≥4 negative weeks occurred between positive samples or when a new HRV genotype was detected in consecutive samples. Samples with HRV PCR cycle threshold values <32 were sequenced at the 5’ non-coding region. Sequences with >98% match to GenBank sequences were identified as known HRV genotypes.

    Results: Of 471 patients (11% ≤ 18 years), 164 (35%) were positive for HRV at least once. Sequencing was completed on 327 samples from 72 patients with 84 HRV episodes. HRV-A was the most common species identified (62% HRV-A, 18% HRV-B, 20% HRV-C). Fifty-three unique genotypes were identified. No molecular evidence of transmission was identified based on lack of significant temporal correlations between genotypes and episodes. The majority of patients demonstrated prolonged shedding of a single HRV genotype, but 9 (12.5%) had multiple illness episodes each with a unique HRV genotype identified. A total of 4/9 (44%) of these patients with multiple episodes were under 18 years of age. Of 63 patients with symptom data available, 15 (24%) were asymptomatic at time of initial viral detection.

    Conclusion: HRV was the most common pathogen identified in this surveillance study of HCT recipients. Sequencing analysis showed little temporal overlap between strains, even with a significant proportion of asymptomatic patients who would not have qualified for respiratory droplet isolation. These data suggest that HRVs are most often community–acquired and that nosocomial spread is less common than expected. Enhanced prevention strategies aimed at minimizing HRV community exposures are needed.

    Alpana Waghmare, MD1,2,3, Jane Kuypers, PhD3, Angela P. Campbell, MD, MPH, FPIDS1, Keith Jerome, MD, PhD4,5, Janet Englund, MD, FIDSA3,6, Michael Boeckh, MD, FIDSA1,3 and Steven Pergam, MD, MPH, FIDSA1,3, (1)Fred Hutchinson Cancer Research Center, Seattle, WA, (2)Seattle Children's Hospital, Seattle, WA, (3)University of Washington, Seattle, WA, (4)Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, (5)Department of Laboratory Medicine, University of Washington, Seattle, WA, (6)Infectious Disease/Cctr, Seattle Children's Hospital, Seattle, WA


    A. Waghmare, None

    J. Kuypers, None

    A. P. Campbell, None

    K. Jerome, None

    J. Englund, None

    M. Boeckh, None

    S. Pergam, None

    << Previous Abstract | Next Abstract

    Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.